Skip to main content
HR 4212 103th Congress House Taxation Accounting Biotechnology Business losses Capital gains tax Commerce Corporation taxes Costs Economics and Public Finance Employee stock options Finance and Financial Sector Income tax Indexing (Economic policy) Labor and Employment Profit Research and development Research and development tax credit Restricted stock options Science, Technology, Communications Stocks

Biotechnology Stimulus Act of 1994

Introduced: April 14, 1994 See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 103rd Congress ended
It never became law before the 103rd Congress (1993–1994) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 21, 1994
Sponsor introductory remarks on measure. (CR H2590)
Apr 14, 1994
Referred to the House Committee on Ways and Means.
Apr 14, 1994
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Biotechnology Stimulus Act of 1994 - Amends the Internal Revenue Code with regard to the biotechnology research credit to: (1) establish an alternative credit calculation based on aggregate research expenses; and (2) make the credit permanent.

Establishes: (1) a biotechnology variable capital gains deduction; and (2) a capital gains exclusion for biotechnology startup business stock held for more than two years.

Provides for the indexing of certain capital assets for purposes of gain or loss determinations.

Expresses the sense of the Congress that accounting standards should not be changed to require that biotechnology businesses deduct the value of stock options from their profits.

What's happening now April 21, 1994

Sponsor introductory remarks on measure. (CR H2590)

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 1
All 1 Republican 1
R
Calvert, Ken
California · Jun 8, 1994
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 4212: Biotechnology Stimulus Act of 1994. 103rd Congress. Open America. https://openamerica.io/bill/103-HR-4212/
MLA
"H.R. 4212: Biotechnology Stimulus Act of 1994." 103rd Congress, 2026, Open America, https://openamerica.io/bill/103-HR-4212/.
Bluebook (legal)
H.R. 4212, 103rd Cong. (2026), https://openamerica.io/bill/103-HR-4212/.
Markdown link
[H.R. 4212: Biotechnology Stimulus Act of 1994](https://openamerica.io/bill/103-HR-4212/)
Report a problem